• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Filing Action Memo, April 20, 2009

Date: 20 April 2009
To: BLA Committee             
From: Lori A. Tull, RAC       
Subject: STN 125348/0 Filing Action        
I have reviewed the Clinical Study Report (Module 5) section(s) of Isolagen Technologies Incorporated’s BLA (STN Number 125348/0) and find the application acceptable for filing.
 (Signature of Committee Member)
(Supervisory Concurrence)